Cedars-Sinai clinical trial studies vaccine targeting cancer stem cells in brain cancers

January 27, 2014

An early-phase clinical trial of an experimental vaccine that targets cancer stem cells in patients with recurrent glioblastoma multiforme, the most common and aggressive malignant brain tumor, has been launched by researchers at Cedars-Sinai’s Department of Neurosurgery, Johnnie L. Cochran, Jr. Brain Tumor Center and Department of Neurology. (Phys.org)